Keeler T Homas Management LLC Bristol Myers Squibb CO Transaction History

Keeler T Homas Management LLC

  • $310 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024
SELL
$48.48 - $57.85 $1.3 Million - $1.55 Million
-26,876 Reduced 38.71%
42,550 $2.18 Million
Q3 2023

Oct 26, 2023
BUY
$57.89 - $64.73 $274,398 - $306,820
4,740 Added 7.33%
69,426 $4.03 Million
Q2 2023

Jul 21, 2023
BUY
$63.71 - $70.74 $1.01 Million - $1.12 Million
15,894 Added 32.58%
64,686 $4.14 Million
Q1 2023

May 02, 2023
BUY
$65.71 - $74.53 $3.21 Million - $3.64 Million
48,792 New
48,792 $3.38 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Keeler T Homas Management LLC Portfolio

Follow Keeler T Homas Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keeler T Homas Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keeler T Homas Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email